Annals of Surgery · 2011 · 228 citations · 22 references
MedicineOncologySurgeryGastrointestinal OncologyMetastasisSurgical OncologyColorectal CancerColorectal SurgeryCytoreductive SurgeryGastrointestinal Cancer SurgeryMalignant NeoplasmsOvarian CancerDisease-free Survival AnalysisDisease-free Survival AssessmentHigh-risk Surgical PatientsManagement Of High-risk PatientsOvarian Peritoneal MetastasesPeritoneal Carcinomatosis SurgeryPeritoneal DisseminationPeritoneal Metastasis Surgery
In Brief Purpose: To analyze the impact of systematic second-look surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) performed 1 year after resection of the primary tumor in asymptomatic patients at high risk of developing peritoneal carcinomatosis (PC). Patients and Methods: From 1999 to 2009, 41 patients without any sign of recurrence on imaging studies underwent second-look surgery aimed at treating limited PC earlier and more easily. They were selected based on 3 primary tumor-associated criteria: resected minimal synchronous macroscopic PC (n = 25), synchronous ovarian metastases (n = 8), and perforation (n = 8). Results: PC was found and treated with complete surgery plus HIPEC in 23 of the 41 (56%) patients. The other patients underwent complete abdominal exploration plus systematic HIPEC. Median follow-up was 30 (9–109) months. One patient died postoperatively at day 69. Grade 3-4 morbidity was low (9.7%). The 5-year overall survival rate was 90% and the 5-year disease-free survival rate was 44%. Peritoneal recurrences occurred in 7 patients (17%), 6 of whom had macroscopic PC discovered during the second-look (26%), and one patient had no macroscopic PC (6%). In the univariate analysis, the presence of PC at second-look surgery was a significant risk factor for recurrence (P = 0.006). Conclusion: Selection criteria for high-risk patients appear to be accurate. In these patients, the second-look strategy treated peritoneal carcinomatosis preventively or at an early stage, yielding promising results. This study has allowed us to design a multicentric randomized trial (comparing the second-look + HIPEC approach versus standard follow-up alone), which is beginning. Peritoneal carcinomatosis was present in more than half of high-risk asymptomatic patients during second-look surgery. The second-look strategy, with systematic HIPEC, treated peritoneal carcinomatosis preventively or at an early stage. The 5-year overall survival rate was 90% and the 5-year disease-free survival rate was 44%.
22
Classification of Surgical Complications
Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien · Annals of Surgery · 2004 · 30.9K citations · Full text
Medicine, Surgery, General Surgery +13
The Clavien-Dindo Classification of Surgical Complications
Pierre A. Clavien, Jeffrey Barkun, Michelle Oliveira et al. · Annals of Surgery · 2009 · 11.3K citations
Victor J. Verwaal, Serge van Ruth, Eelco de Bree et al. · Journal of Clinical Oncology · 2003 · 2K citations
Olivier Gléhen, Fabrice Kwiatkowski, Paul H. Sugarbaker et al. · Journal of Clinical Oncology · 2004 · 1.2K citations
Dominique Élias, François Noël Gilly, Florent Boutitie et al. · Journal of Clinical Oncology · 2009 · 993 citations